Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
This study has been completed.
Study NCT00070174
Information provided by National Cancer Institute (NCI)
First Received: October 3, 2003
Last Updated: March 26, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
